Table 1.
Correlation of CD147 mRNA expression and clinical prognosis in NSCLC for different clinicopathological factors.
| Clinicopathological Characteristic | Overall survival | ||
|---|---|---|---|
| N | Hazard ratio | P | |
| Gender | |||
| Male | 1387 | 1.41 (1.2 - 1.65) | 2.20E-05 |
| Female | 817 | 1.43 (1.13 - 1.8) | 0.0027 |
| Smoking | |||
| Yes | 970 | 1.34 (1.09 - 1.66) | 0.0053 |
| No | 247 | 4.12 (2.15 - 7.9) | 3.70E-06 |
| Grade | |||
| Ⅰ | 202 | 1.39 (0.97 - 2) | 0.0693 |
| Ⅱ | 310 | 1.01 (0.74 - 1.39) | 0.9293 |
| Ⅲ | 77 | 1.3 (0.67 - 2.51) | 0.4336 |
| Stage | |||
| 1 | 652 | 2.22 (1.68 - 2.93) | 9.10E-09 |
| 2 | 320 | 1.95 (1.35 - 2.83) | 0.0004 |
| 3 | 70 | 0.89 (0.51 - 1.56) | 0.6858 |
| 4 | 4 | – | – |
| AJCC Stage T | |||
| 1 | 475 | 1.36 (1.02 - 1.81) | 0.034 |
| 2 | 686 | 1.08 (0.86 - 1.35) | 0.5026 |
| 3 | 99 | 1.37 (0.83 - 2.27) | 0.22 |
| 4 | 48 | 0.87 (0.46 - 1.63) | 0.6557 |
| AJCC Stage N | |||
| 0 | 863 | 1.23 (1 - 1.52) | 0.0551 |
| 1 | 296 | 1.13 (0.83 - 1.55) | 0.4387 |
| 2 | 113 | 0.81 (0.54 - 1.21) | 0.2971 |
| AJCC Stage M | |||
| 0 | 818 | 1.24 (1 - 1.52) | 0.0463 |
| 1 | 10 | – | – |